Editorial
Exosome targeted therapy—a step in the future
Translational Cancer Research
2017;
6
(Suppl 9)
:S1398-S1401
.
(14 December 2017)
In vitro three-dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents
Translational Cancer Research
2017;
6
(Suppl 9)
:S1402-S1405
.
(14 December 2017)
Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes
Translational Cancer Research
2017;
6
(Suppl 9)
:S1406-S1408
.
(14 December 2017)
Living-donor liver transplantation for hepatocellular carcinoma in Japan and Korea
Translational Cancer Research
2017;
6
(Suppl 9)
:S1409-S1411
.
(14 December 2017)
Small hepatocellular carcinoma: which criteria for liver transplantation?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1412-S1413
.
(14 December 2017)
Two’s company, three’s a crowd: the continuing saga of threedrug regimens for extensive-stage small cell lung cancer
Translational Cancer Research
2017;
6
(Suppl 9)
:S1414-S1417
.
(14 December 2017)
Expanding the portfolio of anaplastic lymphoma kinase inhibitors for anaplastic lymphoma kinase-rearranged lung cancers
Translational Cancer Research
2017;
6
(Suppl 9)
:S1418-S1421
.
(14 December 2017)
Dickkopf-1 helps metastasis by immune evasion
Translational Cancer Research
2017;
6
(Suppl 9)
:S1422-S1424
.
(14 December 2017)
Glycation and hepatocellular carcinoma: where we stand
Translational Cancer Research
2017;
6
(Suppl 9)
:S1425-S1427
.
(14 December 2017)
Deletion of tumor progression locus two attenuates alcoholinduced
Translational Cancer Research
2017;
6
(Suppl 9)
:S1428-S1430
.
(14 December 2017)
Have we considered all barriers to mammalian target of rapamycin inhibition as treatment for diffuse intrinsic pontine glioma?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1431-S1434
.
(14 December 2017)
How can we predict hepatic insufficiency after resection of colorectal liver metastases?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1435-S1438
.
(14 December 2017)
TIC10/ONC201—a potential therapeutic in glioblastoma
Translational Cancer Research
2017;
6
(Suppl 9)
:S1439-S1440
.
(14 December 2017)
The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin
Translational Cancer Research
2017;
6
(Suppl 9)
:S1441-S1445
.
(14 December 2017)
Postoperative capecitabine in breast cancer neoadjuvant failures
Translational Cancer Research
2017;
6
(Suppl 9)
:S1446-S1447
.
(14 December 2017)
Crosstalk between circular RNAs and microRNAs in tumorigenesis
Translational Cancer Research
2017;
6
(Suppl 9)
:S1448-S1450
.
(14 December 2017)
Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response
Translational Cancer Research
2017;
6
(Suppl 9)
:S1451-S1454
.
(14 December 2017)
A non-coding RNA axis guides TGF-β-induced gemcitabine chemoresistance
Translational Cancer Research
2017;
6
(Suppl 9)
:S1455-S1457
.
(14 December 2017)
From transcriptional noise to modulator of the TGFB1 pathway, a player in the development of chemoresistance: lncRNA-LET
Translational Cancer Research
2017;
6
(Suppl 9)
:S1458-S1461
.
(14 December 2017)
Association between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative status
Translational Cancer Research
2017;
6
(Suppl 9)
:S1462-S1466
.
(14 December 2017)
A tiny but crucial player bridging microbes and colonic carcinogenesis
Translational Cancer Research
2017;
6
(Suppl 9)
:S1467-S1470
.
(14 December 2017)
Fatigue following head and neck cancer radiotherapy: an unrecognized side effect of modern radiotherapy techniques?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1471-S1475
.
(14 December 2017)
RAD6: a new target to overcome platinum resistance in ovarian cancer?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1476-S1479
.
(14 December 2017)
Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal cancer
Translational Cancer Research
2017;
6
(Suppl 9)
:S1480-S1483
.
(14 December 2017)
Immune checkpoint inhibition in small cell lung cancer: a key to reach an unmet need?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1484-S1488
.
(14 December 2017)
Letter to the Editor
Long term outcomes of stereotactic conformal radiation therapy in the treatment of benign and low-grade brain tumors
Translational Cancer Research
2017;
6
(Suppl 9)
:S1489-S1490
.
(14 December 2017)
Mini-Review
Glycation: a new hope in targeting hepatocellular carcinoma?
Translational Cancer Research
2017;
6
(Suppl 9)
:S1491-S1497
.
(14 December 2017)
Disclosure:
This supplement was published without any sponsorship or funding.
